Site icon Drug Law Journal

New Class Action Brought Against Ethicon and Johnson & Johnson

doctors in surgery

New proceedings have been launched against Ethicon and Johnson & Johnson for manufacturing defective mesh implants. Women implanted with the pelvic floor repair systems after July 4, 2017, may have experienced complications such as chronic pain, painful intercourse, and incontinence. As a result, Shine Lawyers filed a second class action in the Federal Court in early April. 

According to Shine, the first class action was “the largest women’s health class action in Australia’s history”. In November 2019, Justice Anna Katzmann declared that the mesh implants from Ethicon and Johnson & Johnson were “not fit for purpose” and of “unmerchantable quality.”

Shine practice leader Rebecca Jancauskas shares, “We have seen firsthand the terrible impact these products can have on women’s lives, and [these repercussions] drive our team to pursue all available avenues to seek reparations.” 

The new proceedings, headed up by Jancauskas, will include women who did not meet the cut-off date for the first class action. She adds, “We know there are thousands of women who were implanted with these defective products or who have developed complications… That’s why we’ve continued to fight for justice for these women, so none are left behind.” Hundreds of women who expressed interested in the earlier trial are potentially eligible to participate in the second lawsuit. 

A separate lawsuit was recently filed against Boston Scientific Corporation and Boston Scientific Pty Ltd by AJB Stevens Lawyers, also on behalf of women who have suffered due to unacceptable mesh implants. 

For more information about these proceedings, contact us today.

Related Articles:

Hernia Mesh | Lawsuits and Legal Update

Johnson and Johnson seeks to dismiss thousands of talc baby powder lawsuits 

Tracy Everhart is the Editor for Drug Law Journal. A highly-trained and certified medical professional, Tracy is also an accomplished medical writer. After spending years on the front lines of the medical profession, Tracy now devotes her expertise and skills to researching and reporting on new drugs and devices that enter the market, as well as their side-effects and the real-life stories involved. Prior to joining Drug Law Journal, Tracy wrote for benchmark online healthcare resources focused on families and, in particular, women’s health issues. Tracy holds post-graduate degrees from both the American College of Healthcare Sciences and the Yale School of Nursing. She is also a graduate of both Hampshire College, where she studied microbiology and the University of South Carolina school of nursing.